Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Overview of Exosomes

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...

Intralumenal Vesicles and Multivesicular Bodies

Intralumenal Vesicles and Multivesicular Bodies

Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...

Regulation of Hematopoietic Stem Cells

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Topical resiquimod elicits systemic protection and improves anti-PD1 therapy in melanoma via priming of CD8+ T cells.

Cancer immunology research·2026

Same author

A tumor-on-a-chip for in vitro study of CAR-T cell immunotherapy in solid tumors.

Nature biotechnology·2025

Same author

Mechanical regulation of extracellular vesicle activity during tumour progression.

Nature biomedical engineering·2025

Same author

Overcoming extracellular vesicle-mediated fratricide improves CAR T cell treatment against solid tumors.

Nature cancer·2025

Same author

Engineered extracellular vesicles with DR5 agonistic scFvs simultaneously target tumor and immunosuppressive stromal cells.

Science advances·2025

Same author

Macrophage Ferroptotic Resistance Is Required for the Progression of Infantile Hemangioma.

Journal of the American Heart Association·2024

Search research articles

Related Experiment Video

Updated: Aug 19, 2025

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

Published on: September 23, 2021

Immunosuppressive Extracellular Vesicles in CLL.

Wenqun Zhong, Wei Guo¹

¹Department of Biology, University of Pennsylvania, Philadelphia, Pennsylvania.

Blood Cancer Discovery

|December 1, 2022

Summary

Small extracellular vesicles from chronic lymphocytic leukemia cells suppress anti-tumor immunity. These vesicles alter CD8 T-cell function, hindering the immune response against cancer.

Area of Science:

Immunology
Oncology
Cell Biology

Background:

Cancer progression relies on immune evasion.
Chronic lymphocytic leukemia (CLL) is a type of blood cancer.
Extracellular vesicles play roles in intercellular communication.

Discussion:

Small extracellular vesicles (sEVs) from CLL cells were investigated for their impact on antitumor immunity.
The study utilized a mouse model of CLL.
sEVs were found to inhibit the immune system's ability to fight cancer.

Key Insights:

Gargiulo and colleagues demonstrate that sEVs from CLL can impair anti-tumor immune responses.
These vesicles affect the transcriptome, proteome, and metabolome of CD8 T-cells.
This molecular reprogramming of CD8 T-cells contributes to immune suppression.

More Related Videos

Characterization of Immune Cell-derived Extracellular Vesicles and Studying Functional Impact on Cell Environment

Characterization of Immune Cell-derived Extracellular Vesicles and Studying Functional Impact on Cell Environment

Published on: June 2, 2020

Isolation of Low Endotoxin Content Extracellular Vesicles Derived from Cancer Cell Lines

Isolation of Low Endotoxin Content Extracellular Vesicles Derived from Cancer Cell Lines

Published on: February 17, 2023

Related Experiment Videos

Last Updated: Aug 19, 2025

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

Published on: September 23, 2021

Characterization of Immune Cell-derived Extracellular Vesicles and Studying Functional Impact on Cell Environment

Characterization of Immune Cell-derived Extracellular Vesicles and Studying Functional Impact on Cell Environment

Published on: June 2, 2020

Isolation of Low Endotoxin Content Extracellular Vesicles Derived from Cancer Cell Lines

Isolation of Low Endotoxin Content Extracellular Vesicles Derived from Cancer Cell Lines

Published on: February 17, 2023

Outlook:

Understanding sEVs' role in CLL immune evasion could lead to novel therapeutic strategies.
Targeting sEVs may restore CD8 T-cell function and enhance cancer immunotherapy.
Further research is needed to explore the therapeutic potential of targeting sEVs in blood cancers.